The World Health Organization reports there are more than 150 vaccines for COVID-19 in various stages of development. But how do you ensure that everybody is fairly represented in clinical research trials, especially when people of color are dying at higher rates from the virus?
Host Leoneda Inge talks with Kent Thoelke, chief scientific officer and executive vice president of PRA Health Sciences, about the clinical research organization’s efforts to connect with diverse populations for COVID-19 treatment and vaccine trials.
Inge also discusses a recent measure passed by Asheville city council that will provide reparations for the city’s Black community. The resolution calls on the city to create a commission and designate funds to strengthen Black home and business ownership, and close gaps in healthcare, education and employment.